| Literature DB >> 36038188 |
Sungryong Kim1, Su-Jin Kim1,2, Ki-Jeong Na1,3.
Abstract
BACKGROUND: Budgerigar fledgling disease polyomavirus (BFDV) is the pathogen that causes budgerigar fledgling disease in psittacine species. The clinical signs of PBFV infection include ascites, hepatitis, and crop stasis. BFDV is associated with a high mortality rate in nestling birds. In contrast, adult birds only have mild symptoms such as feather dystrophy.Entities:
Keywords: Budgerigar fledgling disease virus; molecular characterization; parrot; phylogenetic analysis; prevalence
Mesh:
Substances:
Year: 2022 PMID: 36038188 PMCID: PMC9523338 DOI: 10.4142/jvs.22082
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.603
Nucleotide sequences of primers designed for this study used to amplify and sequence the full-length genome of budgerigar fledgling disease polyomavirus
| Primers | Sequence (5′-3′) | Location (regions) | Reference |
|---|---|---|---|
| APV-1F | CTTTTCCTCATCCCCTCCTTTGTC | 4853-4876 (t/T-antigen) | Zhuang |
| APV-1R | AGGGGTAGGCGAGTTAGGCTGTGA | 810-833 (VP4) | Zhuang |
| APV-1FSa | CCTACCCTAAACAGGCCCTT | 384-403 (VP4) | This study |
| APV-2F | AGCACTTCTGTCCCTCCTTC | 792-811 (VP4) | This study |
| APV-2R | CACTGACAGCCTCCCACATA | 2176-2195 (VP1) | This study |
| APV-2FSa | AGGAGCGGAATGGTTCTCG | 1329-1347 (VP2/VP3) | This study |
| APV-2RSa | GGGGTTTGCTGTTCTATGGT | 1759-1778 (VP2/VP3) | This study |
| APV-3F | GTACCGTGTTACAGCTGTGC | 2105-2124 (VP1) | This study |
| APV-3R | GAACCAGACACAAACCTGCC | 3404-3423 (T-antigen) | This study |
| APV-3FSa | GTGTACCCTGCACCCCTAAT | 2366-2385 (VP1) | This study |
| APV-3RSa | GGCCCGAAAGTGAAAAGGAG | 3097-3116 (T-antigen) | This study |
| APV-4F | GTTATTACGGAGCGCCTTGG | 3181-3200 (T-antigen) | This study |
| APV-4R | GCTCCTGTGCCTACCTGTAA | 4936-4955 (t/T-antigen) | This study |
| APV-4FSa | TTATCGGTGGGCTGTGCTAA | 3971-3990 (T-antigen) | This study |
| APV-4RSa | GGGTAGCTCATAGTCGGTGG | 4435-4454 (T-antigen) | This study |
aPrimers used for sequencing.
Genera of parrots examined in this study and results of budgerigar fledgling disease polyomavirus examined
| Family | Genus | Positive/Examined (positive rate) |
|---|---|---|
|
|
| 0/7 (0%) |
|
| 0/6 (0%) | |
|
| 0/1 (0%) | |
|
| 0/3 (0%) | |
|
|
| 0/19 (0%) |
|
| 0/24 (0%) | |
|
| 0/1 (0%) | |
|
| 0/1 (0%) | |
|
| 0/15 (0%) | |
|
| 0/18 (0%) | |
|
| 0/1 (0%) | |
|
| 2/28 (7.14%) | |
|
| 2/10 (20%) | |
|
| 0/2 (0%) | |
|
| 0/20 (0%) | |
|
| 1/26 (3.85%) | |
|
| 1/14 (7.14%) | |
|
|
| 0/9 (0%) |
|
| 1/6 (16.7%) | |
|
| 3/6 (50%) | |
| Total | 10/217 (4.61%) |
Sample information of budgerigar fledgling disease polyomavirus-positive
| Sample No. | Accession No. | Species | Age | Domestic location | Sample type | Clinical signs | Gross pathology |
|---|---|---|---|---|---|---|---|
| Strain 1 | NUa | Rose-ringed parakeet ( | 30 d | Chungbuk | Tissue (heart) | Acute death | Petechial hemorrhage on the liver and epicardium |
| Strain 2 | MT981254 | Rose-ringed parakeet ( | 25 d | Chungbuk | Tissue (heart) | Acute death | Petechial hemorrhage on the liver and epicardium, retardation of feather growth |
| Strain 3 | NUb | Budgerigar ( | 2 mon | Chungbuk | Tissue (heart) | Acute death | Petechial hemorrhage on the epicardium |
| Strain 4 | OM640119 | African gray parrot ( | 2 mon | Busan | Feces | No clinical signs | NP |
| Strain 5 | OM640120 | Monk parakeet ( | 20 d | Chungnam | Tissue (heart) | Acute death, crop stasis | Petechial hemorrhage on the skin, liver, and epicardium, ascites |
| Strain 6 | NUa | Green-cheeked conure ( | 2 mon | Chungnam | Feces | Feather dystrophy | NP |
| Strain 7 | OM640121 | Rose-ringed parakeet ( | 1 mon | Busan | Tissue (heart) | Acute death | Petechial hemorrhage on the epicardium |
| Strain 8 | OM640122 | Black-headed parrot ( | 2 mon | Gyeonggi | Tissue (heart) | Acute death | Petechial hemorrhage on the epicardium |
| Strain 9 | OM640123 | Black-headed parrot ( | 2 mon | Ulsan | Tissue (heart) | Acute death | Petechial hemorrhage on the epicardium |
| Strain 10 | NUb | Monk parakeet ( | 3 yr | Daejeon | Feces | Multifocal alopecia, self-mutilation | NP |
NU, not uploaded; NP, not performed.
aIdentical sequence, bfailed to obtain whole genome sequence.
Fig. 1Estimated phylogenetic trees showing relationship among reference sequences of BFDV. The phylogenetic analysis reveals that all BFDV strains were largely divided into group I and group II. The star (⋆) indicates strains obtained in this study. The bootstrap value on the branch represents the percentage of 1000 bootstrap replicates and only values above 70% are displayed. The neighbor-joining algorithm applied to Tamura-Nei genetic distances as implemented by MEGA11 software.
BFDV, budgerigar fledgling disease polyomavirus.
Point mutations in six strains of budgerigar fledgling disease polyomaviruses compared with consensus
| Nucleotide number | Region | Consensus | Nucleotide exchange (amino acid substitutaion) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT981254 | OM640119 | OM640120 | OM640121 | OM640122 | OM640123 | AB453159 | AB453162 | AB453163 | AB453165 | FJ385773 | GU452537 | KT203762 | KT203767 | KT203768 | KT203769 | MH643735 | MK516256 | MN657184 | |||
| 28 | Non-coding | A | T | ||||||||||||||||||
| 34 | Non-coding | T | A | A | |||||||||||||||||
| 343 | VP4 (intron) | C | T | T | T | T | T | ||||||||||||||
| 609 | VP4 (intron) | T | C | C | C | C | C | C | C | ||||||||||||
| 670 | VP4 | T | C(F→L) | C(F→L) | C(F→L) | ||||||||||||||||
| 711 | VP4 | A | C(Q→H) | C(Q→H) | C(Q→H) | ||||||||||||||||
| 741 | VP4 | T | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | ||||||||||||
| 831 | VP4 | C | T(-) | ||||||||||||||||||
| 921 | VP4 | T | C(-) | ||||||||||||||||||
| 1301 | VP2/VP3 | C | T(-) | T(-) | |||||||||||||||||
| 1513 | VP2/VP3 | G | A(-) | ||||||||||||||||||
| 1519 | VP2/VP3 | A | C(-) | C(-) | |||||||||||||||||
| 1534 | VP2/VP3 | T | G(-) | ||||||||||||||||||
| 1543 | VP2/VP3 | A | G(-) | ||||||||||||||||||
| 1591 | VP2/VP3 | G | T(-) | ||||||||||||||||||
| 1654 | VP2/VP3 | G | A(-) | ||||||||||||||||||
| 1677 | VP2/VP3 | G | A(R→H) | A(R→H) | A(R→H) | A(R→H) | A(R→H) | A(R→H) | |||||||||||||
| 1694 | VP2/VP3 | T | C(S→P) | A(S→T) | A(S→T) | A(S→T) | A(S→T) | A(S→T) | C(S→P) | ||||||||||||
| 1722 | VP2/VP3 | A | G(K→R) | G(K→R) | G(K→R) | ||||||||||||||||
| 1723 | VP2/VP3 | A | C(K→N) | ||||||||||||||||||
| 1766 | VP2/VP3 | C | G(Q→E) | ||||||||||||||||||
| 2151 | VP1 | A | C(T→P) | ||||||||||||||||||
| 2177 | VP1 | G | T(-) | A(-) | A(-) | ||||||||||||||||
| 2474 | VP1 | T | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | |||||||||||
| 2512 | VP1 | A | G(K→R) | G(K→R) | G(K→R) | ||||||||||||||||
| 2525 | VP1 | T | C(-) | ||||||||||||||||||
| 2546 | VP1 | A | T(-) | T(-) | |||||||||||||||||
| 2558 | VP1 | G | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | |||||||||||
| 2600 | VP1 | T | C(-) | C(-) | |||||||||||||||||
| 2663 | VP1 | A | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | C(-) | |||||||||||
| 2744 | VP1 | G | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | A(-) | |||||||||||
| 2759 | VP1 | T | G(-) | ||||||||||||||||||
| 2906 | VP1 | C | T(-) | T(-) | T(-) | T(-) | T(-) | T(-) | T(-) | T(-) | T(-) | ||||||||||
| 2945 | Non-coding | C | A | A | A | A | A | A | A | A | |||||||||||
| 3063 | T-antigen | T | G(N→E) | G(N→E) | G(N→E) | G(N→E) | G(N→E) | G(N→E) | |||||||||||||
| 3122 | T-antigen | G | T(-) | T(-) | |||||||||||||||||
| 3224 | T-antigen | G | A(-) | ||||||||||||||||||
| 3242 | T-antigen | A | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | |||||||||||||
| 3413 | T-antigen | A | C(-) | C(-) | |||||||||||||||||
| 3506 | T-antigen | A | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | ||||||||||||
| 3663 | T-antigen | T | G(D→A) | ||||||||||||||||||
| 3721 | T-antigen | C | A(A→S) | A(A→S) | |||||||||||||||||
| 3962 | T-antigen | C | T(-) | T(-) | |||||||||||||||||
| 4125 | T-antigen | G | A(P→L) | A(P→L) | A(P→L) | A(P→L) | A(P→L) | A(P→L) | |||||||||||||
| 4292 | T-antigen | A | G(-) | G(-) | |||||||||||||||||
| 4430 | T-antigen | A | T(-) | - | T(-) | ||||||||||||||||
| 4769 | T/t-antigen | G | T(-) | T(-) | |||||||||||||||||
| 4811 | T/t-antigen | G | A(-) | A(-) | A(-) | ||||||||||||||||
| 4910 | T/t-antigen | A | G(-) | ||||||||||||||||||
| 4948 | T/t-antigen | C | A(G→C) | ||||||||||||||||||
| 4967 | T/t-antigen | G | C(-) | ||||||||||||||||||
| 4972 | T/t-antigen | A | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | G(-) | ||||||||||
Minuses indicate the silent mutation positions. Blanks indicate identical nucleotide.
Numbers of nucleotide and amino acid substitutions in this study compared with the consensus sequences
| Accession No. | bp | No of nucleotide substitutions | VP1 (344 aa) | VP2 (342 aa) | VP3 (236 aa) | VP4 (177 aa) | Larg T (600 aa) | Small t (146 aa) |
|---|---|---|---|---|---|---|---|---|
| MT981254 | 4981 | 11 (0.2%) | 1 (0.3%) | 1 (0.3%) | 1 (0.4%) | 1 (0.2%) | ||
| OM640119 | 4981 | 13 (0.3%) | 1 (0.3%) | 3 (0.9%) | 3 (1.3%) | 1 (0.2%) | 1 (0.7%) | |
| OM640120 | 4981 | 15 (0.3%) | 2 (0.3%) | |||||
| OM640121 | 4981 | 12 (0.2%) | 1 (0.3%) | 1 (0.4%) | 1 (0.6%) | 3 (0.5%) | ||
| OM640122 | 4981 | 11 (0.2%) | 1 (0.3%) | 1 (0.4%) | 1 (0.6%) | 3 (0.5%) | ||
| OM640123 | 4981 | 13 (0.3%) | 1 (0.3%) | 1 (0.4%) | 1 (0.6%) | 3 (0.5%) | ||
| Sequence diversity rate | 0.2%–0.3% | 0%–0.3% | 0.3%–0.9% | 0.4%–1.3% | 0%–0.6% | 0.2%–0.5% | 0%–0.7% |
Blank cells indicate no predicted amino acid substitutions.
bp, base pairs; aa, amino acid.